Pursuant to Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Unichem Laboratories has enclosed the result of remote e-voting in the prescribed format along with Scrutinizer's consolidated report for the following resolutions which were proposed for the approval of the Members through Postal Ballot: a. Appointment of Dr. (Ms) Swati Patankar (DIN 06594600) as a Non-Executive Independent Director for a term of five years with effect from 5th February 2026; b. Material related party transaction(s) between Ipca Laboratories, holding company of Unichem Laboratories and Unichem Pharmaceuticals USA Inc. (Unichem USA), wholly owned subsidiary of Unichem; c. Material related party transaction(s) with Unichem USA, wholly owned subsidiary of Unichem. The resolutions as proposed in the postal ballot notice have been passed by the shareholders by remote e-voting process with requisite majority and are deemed to be passed on the last date of the remote e-voting period i.e. Friday, 27th March 2026. The said results and the scrutinizer’s report will be available on the Company’s website i.e. www.unichemlabs.com and that of the exchanges namely www.bseindia.com and www.nseindia.com and the website of the e-voting agency i.e. https://www.evoting.nsdl.com.

The above information is a part of company’s filings submitted to BSE.